ZOETIS INC. - ZTS STOCK NEWS

Zoetis (NYSE:ZTS) will participate in the TD Cowen Health Care Conference on March 6, 2023. Wetteny Joseph, Executive Vice President and CFO, is set to present at 11:10 a.m. ET and address questions from analysts. A live audio webcast will be available at investor.zoetis.com/events-presentations. Following the event, a replay will be accessible on the Zoetis website. As a leading animal health company, Zoetis focuses on enhancing animal care globally, with $8.1 billion in revenue in 2022 and around 13,800 employees.

Zoetis has secured a $15.3 million grant from the Bill & Melinda Gates Foundation to enhance veterinary care and livestock productivity in Sub-Saharan Africa. This funding will broaden the existing African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative to include aquaculture and expand into seven new countries, including Ethiopia, Nigeria, Tanzania, Uganda, and Kenya. Over five years, the program aims to train 100,000 stakeholders and improve access to veterinary products, especially for female farmers. This initiative is part of Zoetis' commitment to support sustainable agricultural practices in rapidly developing regions.

Zoetis (NYSE: ZTS) will participate in the Bank of America Securities 2023 Animal Health Summit on March 2, 2023, at 12:30 p.m. ET. The company will be represented by Wetteny Joseph, Executive VP and CFO, who will answer questions from analysts. A live audio webcast will be available for interested parties at investor.zoetis.com/events-presentations. A replay will also be accessible after the event. Zoetis, a leading global animal health company, focuses on advancing animal care and reported revenues of $8.1 billion in 2022.

Zoetis reported its financial results for Q4 and the full year of 2022, achieving a revenue of $2.0 billion for Q4, up 4% year-over-year. The company’s net income for Q4 was $461 million, equating to $0.99 per diluted share. For the full year, Zoetis posted revenues of $8.1 billion, also reflecting a 4% increase, with net income reaching $2.1 billion or $4.49 per diluted share. Looking ahead, Zoetis expects 2023 revenue between $8.575 billion and $8.725 billion, with an operational growth forecast of 6% to 8%. Key growth drivers included companion animal products, although livestock product sales faced challenges from competition and supply issues.

The Board of Directors of Zoetis (NYSE:ZTS) has declared a dividend of $0.375 per share for Q2 2023. This dividend will be distributed on June 1, 2023, to shareholders on record as of April 21, 2023. Zoetis is a leading animal health company, generating $7.8 billion in revenue in 2021. With over 70 years of experience, they provide innovative solutions for animal care globally.

For more information on their products and services, visit www.zoetis.com.

Zoetis Inc (NYSE:ZTS) will hold a webcast and conference call on February 14, 2023, at 8:30 a.m. ET to discuss its fourth quarter and full year 2022 financial results. CEO Kristin Peck and CFO Wetteny Joseph will present and answer questions from analysts. Investors can access the live webcast via the Zoetis website and a replay will be available following the event. Zoetis, a leading global animal health company, reported $7.8 billion in revenue for 2021 and continues to innovate in animal care across over 100 countries.

Zoetis (NYSE: ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023. CEO Kristin Peck is scheduled to present at 1:30 p.m. PT and answer analyst questions. Investors can access a live audio webcast of the presentation through the company's investor relations site. A replay will also be available post-event. Zoetis, a leading animal health company, generated $7.8 billion in revenue in 2021 and operates in over 100 countries, focusing on animal care and health innovations.

The Board of Directors of Zoetis has announced a dividend of $0.375 per share for Q1 2023, marking a 15% increase from 2022. This dividend will be paid on March 1, 2023, to shareholders on record as of January 20, 2023. Executive VP and CFO Wetteny Joseph highlighted the company's robust product portfolio and global presence as key factors for generating increased cash flow for future investments and returning capital to shareholders.

Zoetis (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022. Glenn David, Executive Vice President and Group President of U.S. Operations, will present at 3:30 p.m. ET. Investors can access a live audio webcast of the presentation at investor.zoetis.com/events-presentations. A replay will be available post-event. As a leading animal health company, Zoetis aims to improve animal care globally, generating $7.8 billion in revenue in 2021.